Ginkgo Bioworks Holdings, Inc. (DNA)
NYSE: DNA · Real-Time Price · USD
13.18
+0.28 (2.17%)
At close: Aug 15, 2025, 4:00 PM
12.97
-0.21 (-1.59%)
After-hours: Aug 15, 2025, 7:43 PM EDT
Ginkgo Bioworks Holdings Market Cap
Ginkgo Bioworks Holdings has a market cap or net worth of $730.51 million as of August 15, 2025. Its market cap has decreased by -13.73% in one year.
Market Cap
730.51M
Enterprise Value
685.64M
1-Year Change
-13.73%
Ranking
Category
Stock Price
$13.18
Market Cap Chart
Since April 19, 2021, Ginkgo Bioworks Holdings's market cap has decreased from $2.18B to $730.51M, a decrease of -66.52%. That is a compound annual growth rate of -22.35%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 15, 2025 | 730.51M | 40.14% |
| Dec 31, 2024 | 521.27M | -84.36% |
| Dec 29, 2023 | 3.33B | 16.75% |
| Dec 30, 2022 | 2.86B | -76.89% |
| Dec 31, 2021 | 12.35B | 466.18% |
| Apr 19, 2021 | 2.18B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 629.52B |
| Johnson & Johnson | 425.41B |
| AbbVie | 365.13B |
| UnitedHealth Group | 275.33B |
| AstraZeneca | 243.89B |
| Novartis AG | 239.15B |
| Abbott Laboratories | 229.31B |
| Novo Nordisk | 227.24B |